Guidance
← Earnings Calls
01
02
03
04 05 06
Tone
AI
Capex
A1 A2 A3
XYL
FY2025 Q4
In line
Xylem Inc. earnings call
Buzzberg read
2026 organic growth guided 2-4%, with 2% headwind from 80-20 walkaways
Xylem reported strong Q4 2025 results, closing a record year with record revenue, EBITDA, and EPS, driven by operational discipline and transformation initiatives. However, 2026 guidance is mixed: while margin expansion and EPS growth continue, organic revenue growth is guided to the low end of the long-term framework due to deliberate 80-20 walkaways (doubling to ~2% headwind) and continued weakness in China. Q4 2025 was a strong finish, with record quarterly revenue, EBITDA margin of 23.2%, and EPS of $1.42, up 20% YoY.
Buzzberg read 2026 organic growth guided 2-4%, with 2% headwind from 80-20 walkaways Xylem reported strong Q4 2025 results, closing a record year with record revenue, EBITDA, and EPS, driven by operational discipline and transformation initiatives. However, 2026 guidance is mixed: while margin expansion and EPS growth continue, organic revenue growth is guided to the low end of the long-term framework due to deliberate 80-20 walkaways (doubling to ~2% headwind) and continued weakness in China. Q4 2025 was a strong finish, with record quarterly revenue, EBITDA margin of 23.2%, and EPS of $1.42, up 20% YoY. Read full analysisCollapse analysis
Xylem reported strong Q4 2025 results, closing a record year with record revenue, EBITDA, and EPS, driven by operational discipline and transformation initiatives. However, 2026 guidance is mixed: while margin expansion and EPS growth continue, organic revenue growth is guided to the low end of the long-term framework due to deliberate 80-20 walkaways (doubling to ~2% headwind) and continued weakness in China. Q4 2025 was a strong finish, with record quarterly revenue, EBITDA margin of 23.2%, and EPS of $1.42, up 20% YoY.
- 2025 full-year revenue grew 5% organic, with EBITDA margin expanding 160bps to 22.2%.
- 2026 guidance implies 2-4% organic growth, deliberately dented by a 2% headwind from 80-20 simplification, but EBITDA margins are expected to expand another 70-110bps.
- China remains a significant drag, with Q4 orders down nearly 70% and sales down ~30%; management has restructured operations and is strategically exiting low-quality business there.
Revenue$2.397BReported
EPS$1.42Reported
Gross margin38.88%Reported
Operating margin14.73%Reported
6 grounded callouts
What matters now
The highest-signal changes from the call.
China
China weakness accelerated, orders down 70% in Q4
Demand
MCS backlog normalization and project timing pressure 2026 growth
Show 3 more callouts
Margins
Company expects to hit >23% EBITDA margin in 2026, ahead of 2027 target
Strategy
Management plans investor day in spring 2027 to update targets
AI
AI-related water demand to surge 130% by 2050, Xylem positioned to benefit
Reported period
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $2.397B | Reported |
| EPS | $1.42 | Reported |
| Gross margin | 38.88% | Reported |
| Operating margin | 14.73% | Reported |
| Free cash flow | $0.46B | Reported |
| Capex | $0.083B | Reported |
Forward-looking
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| EPS | FY2026 | $5.35–$5.60 | $5.47 | Maintained |
| EPS | FY2026 Q1 | $1.06–$1.11 | $1.08 | Maintained |
| Revenue | FY2026 | $9.1B–$9.2B | $9.15B | Maintained |
AI, capex & demand read
Management read
Confident
Management expressed confidence in long-term growth and margin expansion, highlighting record results, strategic progress, and strong demand, while acknowledging near-term headwinds from deliberate portfolio actions and market softness in China.
Management AI read
Management highlighted water as foundational to AI-driven economic growth, citing a commissioned report showing the AI ecosystem will need 30 trillion liters of water annually by 2050, and positioned Xylem's full water value chain as uniquely able to solve related water challenges, with growth opportunities in power, data centers, and microelectronics.
Investment and capacity
Management did not discuss its own capital expenditure or capacity investments in detail, but noted plans to deploy about $1 billion annually towards M&A and be more active in share buybacks at low leverage levels.
External signals
Supply-chain alpha · 3returns since call
Xylem is accelerating its 80-20 product and customer simplification, doubling the top-line headwind to ~2% in 2026. This is a deliberate one-year elevation as they exit unprofitable or low-margin business, which will reallocate capacity towards higher-value opportunities.
Evidence
“As a result, we will have an outsized headwind to our top line for the year of roughly 2%, doubling the impact we experienced in 2025. We expect this is a one-year elevation, and we are still committed to delivering on our long-term framew…”
China's deterioration accelerated significantly in Q4, with orders down almost 70% and sales down nearly 30%. Xylem is using its 80-20 lens to intentionally exit low-margin China business and has reduced headcount by over 40%, expecting no material improvement in the next 1-2 years.
Evidence
“Q4 orders were down almost 70%. Sales declined almost 30%. Our teams are applying an 80-20 lens to focus on higher quality, more profitable opportunities, which is creating some of the top-line pressure.”
Within MCS, the biggest area of 80-20 walkaway is in analytics, one of the last divisions to implement the tool. Management expects this to impact segment growth in 2026, but Xylem View, a digital business, doubled in 2025 and is expected to grow 30%+ in 2026, helping to offset the drag.
Evidence
“The biggest area of walk-away in this segment is in analytics. It's one of the last divisions to go into the 80-20 tool. I would highlight the Xylem View business, which doubled in 2025. We're expecting that digital business to grow 30 plu…”
Methodology & coverage
Management-only analysis. All 0 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.